Quantitative whole body biodistribution of fluorescent-labeled agents by non-invasive tomographic imaging

PLoS ONE

Volumn 6, Issue 6, 2011, Pages

  Vasquez, Kristine O ^a   Casavant, Chelsea ^a   Peterson, Jeffrey D ^a  

^a PERKINELMER INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOSENSE; ANGIOSPARK; BOVINE SERUM ALBUMIN; CARDIOVASCULAR AGENT; FLUORESCENT DYE; GASTROSENSE 750; IMMUNOGLOBULIN G1; INTEGRIN INHIBITOR; NANOPARTICLE; PROSENSE; PROTEIN INHIBITOR; RENINSENSE; UNCLASSIFIED DRUG; VIVOTAG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BLADDER; BRAIN; CONTRAST ENHANCEMENT; CONTROLLED STUDY; DRUG CLEARANCE; DRUG DISTRIBUTION; FAR RED IMAGING; FEMALE; FLUORESCENCE IMAGING; FLUORESCENCE MOLECULAR TOMOGRAPHY; HEART; IMAGE ANALYSIS; IMAGING; KIDNEY; LIVER; LUNG; MOUSE; NEAR INFRARED IMAGING; NONHUMAN; QUANTITATIVE STUDY; SIGNAL DETECTION; THREE DIMENSIONAL IMAGING; TISSUE DISTRIBUTION; ANIMAL; ANTIBODY SPECIFICITY; CATTLE; KINETICS; METABOLISM; METHODOLOGY; NEAR INFRARED SPECTROSCOPY; REPRODUCIBILITY; STAINING; TIME; TOMOGRAPHY; WHOLE BODY IMAGING;

ANIMALIA; MUS;

ANIMALS; CATTLE; FEMALE; FLUORESCENT DYES; KIDNEY; KINETICS; LIVER; MICE; ORGAN SPECIFICITY; REPRODUCIBILITY OF RESULTS; SERUM ALBUMIN, BOVINE; SPECTROSCOPY, NEAR-INFRARED; STAINING AND LABELING; TIME FACTORS; TISSUE DISTRIBUTION; TOMOGRAPHY; WHOLE BODY IMAGING;

EID: 79959381499     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0020594     Document Type: Article

References (29)

1. Takakura Y, Hashida M, (1996) Macromolecular carrier systems for targeted drug delivery: pharmacokinetic considerations on biodistribution. Pharm Res 13: 820-831.
2. Kenanova V, Olafsen T, Crow DM, Sundaresan G, Subbarayan M, et al. (2005) Tailoring the pharmacokinetics and positron emission tomography imaging properties of anti-carcinoembryonic antigen single-chain Fv-Fc antibody fragments. Cancer Res 65: 622-631.
3. Tabrizi M, Bornstein GG, Suria H, (2009) Biodistribution mechanisms of therapeutic monoclonal antibodies in health and disease. AAPS J 12: 33-43.
4. Banzato A, Rondina M, Melendez-Alafort L, Zangoni E, Nadali A, et al. (2009) Biodistribution imaging of a paclitaxel-hyaluronan bioconjugate. Nucl Med Biol 36: 525-533.
5. Zhang Z, Liang K, Bloch S, Berezin M, Achilefu S, (2005) Monomolecular multimodal fluorescence-radioisotope imaging agents. Bioconjug Chem 16: 1232-1239.
6. Seo Y, (2008) Quantification of SPECT and PET for Drug Development. Current Radiopharmaceuticals 1: 17-21.
7. Yang Z, Leon J, Martin M, Harder JW, Zhang R, et al. (2009) Pharmacokinetics and biodistribution of near-infrared fluorescence polymeric nanoparticles. Nanotechnology 20: 165101.
8. Priyadarshani A, Chuttani K, Mittal G, Bhatnagar A, (2010) Radiolabeling, biodistribution and gamma scintigraphy of noscapine hydrochloride in normal and polycystic ovary induced rats. J Ovarian Res 3: 10.
9. Boss DS, Olmos RV, Sinaasappel M, Beijnen JH, Schellens JH, (2008) Application of PET/CT in the development of novel anticancer drugs. Oncologist 13: 25-38.
10. Robe A, Pic E, Lassalle HP, Bezdetnaya L, Guillemin F, et al. (2008) Quantum dots in axillary lymph node mapping: biodistribution study in healthy mice. BMC Cancer 8: 111.
11. Yaseen MA, Yu J, Jung B, Wong MS, Anvari B, (2009) Biodistribution of encapsulated indocyanine green in healthy mice. Mol Pharm 6: 1321-1332.
12. Ntziachristos V, Bremer C, Weissleder R, (2003) Fluorescence imaging with near-infrared light: new technological advances that enable in vivo molecular imaging. Eur Radiol 13: 195-208.
13. Ntziachristos V, Bremer C, Graves EE, Ripoll J, Weissleder R, (2002) In vivo tomographic imaging of near-infrared fluorescent probes. Mol Imaging 1: 82-88.
14. Zilberman Y, Kallai I, Gafni Y, Pelled G, Kossodo S, et al. (2008) Fluorescence molecular tomography enables in vivo visualization and quantification of nonunion fracture repair induced by genetically engineered mesenchymal stem cells. J Orthop Res 26: 522-530.
15. Wunder A, Tung CH, Muller-Ladner U, Weissleder R, Mahmood U, (2004) In vivo imaging of protease activity in arthritis: a novel approach for monitoring treatment response. Arthritis Rheum 50: 2459-2465.
16. Korideck H, Peterson JD, (2009) Noninvasive quantitative tomography of the therapeutic response to dexamethasone in ovalbumin-induced murine asthma. J Pharmacol Exp Ther 329: 882-889.
17. Nahrendorf M, Waterman P, Thurber G, Groves K, Rajopadhye M, et al. (2009) Hybrid In Vivo FMT-CT Imaging of Protease Activity in Atherosclerosis With Customized Nanosensors. Arterioscler Thromb Vasc Biol.
18. Peterson JD, Labranche TP, Vasquez KO, Kossodo S, Melton M, et al. (2010) Optical tomographic imaging discriminates between disease-modifying anti-rheumatic drug (DMARD) and non-DMARD efficacy in collagen antibody-induced arthritis. Arthritis Res Ther 12: R105.
19. Kozloff KM, Weissleder R, Mahmood U, (2007) Noninvasive optical detection of bone mineral. J Bone Miner Res 22: 1208-1216.
20. Kossodo S, Pickarski M, Lin SA, Gleason A, Gaspar R, et al. (2009) Dual in vivo quantification of integrin-targeted and protease-activated agents in cancer using fluorescence molecular tomography (FMT). Mol Imaging Biol 12: 488-499.
21. Stangenberg L, Ellson C, Cortez-Retamozo V, Ortiz-Lopez A, Yuan H, et al. (2009) Abrogation of antibody-induced arthritis in mice by a self-activating viridin prodrug and association with impaired neutrophil and endothelial cell function. Arthritis Rheum 60: 2314-2324.
22. Montet X, Figueiredo JL, Alencar H, Ntziachristos V, Mahmood U, et al. (2007) Tomographic fluorescence imaging of tumor vascular volume in mice. Radiology 242: 751-758.
23. Buono C, Anzinger JJ, Amar M, Kruth HS, (2009) Fluorescent pegylated nanoparticles demonstrate fluid-phase pinocytosis by macrophages in mouse atherosclerotic lesions. J Clin Invest 119: 1373-1381.
24. Ackerman ME, Pawlowski D, Wittrup KD, (2008) Effect of antigen turnover rate and expression level on antibody penetration into tumor spheroids. Mol Cancer Ther 7: 2233-2240.
25. Hoyt RF, Hawkins JV, Claire MB St, Kennett MB, (2007) Mouse Physiology. In: Fox JG, Barthold SW, Davisson MT, Newcomer CE, Quimby FW et al, editors. The Mouse in Biomedical Research: Diseases. 2nd ed London, UK Academic Press pp. 23-90.
26. Grimm J, Kirsch DG, Windsor SD, Kim CF, Santiago PM, et al. (2005) Use of gene expression profiling to direct in vivo molecular imaging of lung cancer. Proc Natl Acad Sci U S A 102: 14404-14409.
27. Mahmood U, Weissleder R, (2003) Near-infrared optical imaging of proteases in cancer. Mol Cancer Ther 2: 489-496.
28. Peterson J, Labranche T, Vasquez K, Kossodo S, Melton M, et al. (2010) Optical tomographic imaging discriminates between disease-modifying anti-rheumatic drug (dmard) and non-dmard efficacy in collagen antibody-induced arthritis. Arthritis Research & Therapy 12: R105.
29. Mohajerani P, Adibi A, Kempner J, Yared W, (2009) Compensation of optical heterogeneity-induced artifacts in fluorescence molecular tomography: theory and in vivo validation. J Biomed Opt 14: 034021.